These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2654809)

  • 1. Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene.
    Konieczny SF; Drobes BL; Menke SL; Taparowsky EJ
    Oncogene; 1989 Apr; 4(4):473-81. PubMed ID: 2654809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoblast alpha v beta3 integrin levels are controlled by transcriptional regulation of expression of the beta3 subunit and down-regulation of beta3 subunit expression is required for skeletal muscle cell differentiation.
    Blaschuk KL; Guérin C; Holland PC
    Dev Biol; 1997 Apr; 184(2):266-77. PubMed ID: 9133434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional down-regulation of myogenin expression is associated with v-ras-induced block of differentiation in unestablished quail muscle cells.
    Russo S; Tatò F; Grossi M
    Oncogene; 1997 Jan; 14(1):63-73. PubMed ID: 9010233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental regulation of intermediate filament and actin mRNAs during myogenesis is disrupted by oncogenic ras genes.
    Olson EN; Capetanaki YG
    Oncogene; 1989 Jul; 4(7):907-13. PubMed ID: 2666910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation.
    Weyman CM; Wolfman A
    Oncogene; 1997 Nov; 15(21):2521-8. PubMed ID: 9399640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
    Haider SR; Wang W; Kaufman SJ
    Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway.
    Conejo R; de Alvaro C; Benito M; Cuadrado A; Lorenzo M
    Oncogene; 2002 May; 21(23):3739-53. PubMed ID: 12032842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive regulation of skeletal myogenesis by R-Ras.
    Suzuki J; Kaziro Y; Koide H
    Oncogene; 2000 Feb; 19(9):1138-46. PubMed ID: 10713701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation.
    Sorrentino V; Pepperkok R; Davis RL; Ansorge W; Philipson L
    Nature; 1990 Jun; 345(6278):813-5. PubMed ID: 2359457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C.
    Vaidya TB; Weyman CM; Teegarden D; Ashendel CL; Taparowsky EJ
    J Cell Biol; 1991 Aug; 114(4):809-20. PubMed ID: 1714463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Ras-induced effects on skeletal myoblast differentiation and apoptosis are independent of constitutive PI3-kinase activity.
    Karasarides M; Dee K; Schulman D; Wolfman A; Weyman CM
    Cell Biol Int; 2006 Apr; 30(4):308-18. PubMed ID: 16503174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism.
    Delgado MD; Vaqué JP; Arozarena I; López-Ilasaca MA; Martínez C; Crespo P; León J
    Oncogene; 2000 Feb; 19(6):783-90. PubMed ID: 10698496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ras suppressor, RSU-1, enhances nerve growth factor-induced differentiation of PC12 cells and induces p21CIP expression.
    Masuelli L; Ettenberg S; Vasaturo F; Vestergaard-Sykes K; Cutler ML
    Cell Growth Differ; 1999 Aug; 10(8):555-64. PubMed ID: 10470855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of PKR in the regulation of myogenesis.
    Kronfeld-Kinar Y; Vilchik S; Hyman T; Leibkowicz F; Salzberg S
    Cell Growth Differ; 1999 Mar; 10(3):201-12. PubMed ID: 10099834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of orthovanadate on commitment of avian myoblasts transformed with Rous sarcoma virus to myogenic differentiation.
    Hase H; Isobe A; Kim J
    Eur J Cell Biol; 1995 Nov; 68(3):313-22. PubMed ID: 8603684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of H-ras in erythroid differentiation of TF1 and human umbilical cord blood CD34 cells.
    Ge Y; Li ZH; Marshall MS; Broxmeyer HE; Lu L
    Blood Cells Mol Dis; 1998 Jun; 24(2):124-36; discussion 137. PubMed ID: 9628849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineating v-Src downstream effector pathways in transformed myoblasts.
    Ciuffini L; Castellani L; Salvati E; Galletti S; Falcone G; Alemà S
    Oncogene; 2008 Jan; 27(4):528-39. PubMed ID: 17637741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
    Yang W; Chen Y; Zhang Y; Wang X; Yang N; Zhu D
    Cancer Res; 2006 Feb; 66(3):1320-6. PubMed ID: 16452185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1.
    Wang J; Helin K; Jin P; Nadal-Ginard B
    Cell Growth Differ; 1995 Oct; 6(10):1299-306. PubMed ID: 8845307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels.
    Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S
    Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.